(3S,4R)-N-hydroxy-3-methyl-4-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]-1-prop-2-yn-1-ylpiperidine-3-carboxamide

ID: ALA4084692

PubChem CID: 57848909

Max Phase: Preclinical

Molecular Formula: C27H30N4O5S

Molecular Weight: 522.63

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C#CCN1CC[C@@H](NS(=O)(=O)c2ccc(OCc3cc(C)nc4ccccc34)cc2)[C@@](C)(C(=O)NO)C1

Standard InChI:  InChI=1S/C27H30N4O5S/c1-4-14-31-15-13-25(27(3,18-31)26(32)29-33)30-37(34,35)22-11-9-21(10-12-22)36-17-20-16-19(2)28-24-8-6-5-7-23(20)24/h1,5-12,16,25,30,33H,13-15,17-18H2,2-3H3,(H,29,32)/t25-,27+/m1/s1

Standard InChI Key:  MWKQFYFRXFGWCL-VPUSJEBWSA-N

Molfile:  

     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   10.4623   -8.5915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8790   -9.3081    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.2913   -8.5890    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7359   -8.4706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7347   -9.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4495   -9.7108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4477   -8.0579    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1631   -8.4670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1638   -9.2938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8791   -9.7048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5941   -9.2901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5893   -8.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8735   -8.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0212   -8.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4513  -10.5358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7379  -10.9500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0224  -10.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0252   -9.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3106   -9.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5962   -9.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6007  -10.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3159  -10.9546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1673   -9.7236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1703  -10.5486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4561  -10.9573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4571  -11.7787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1713  -12.1924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8862  -11.7786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8868  -10.9510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7422  -10.5439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7433   -9.7189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0272  -10.9555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3133  -10.5421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8665  -11.5373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1712  -13.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4567  -13.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7422  -13.8422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20  2  1  0
  2 23  1  0
 24 23  1  6
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 25 30  1  6
 30 31  2  0
 30 32  1  0
 32 33  1  0
 25 34  1  0
 27 35  1  0
 35 36  1  0
 36 37  3  0
M  END

Alternative Forms

1. Parent:

   

   ALA4084692

   (3S,4R)-N-hydroxy-3-methyl-4-[[4-[(2-methylquinolin-4-yl)methoxy]phenyl]sulfonylamino]-1-prop-2-ynylpiperidine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 522.63

Molecular Weight (Monoisotopic): 522.1937

AlogP: 2.62

#Rotatable Bonds: 8

Polar Surface Area: 120.86

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.81

CX Basic pKa: 6.94

CX LogP: 2.17

CX LogD: 2.12

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.24

Np Likeness Score: -1.05

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source

Source(1):

• Scientific Literature